Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Big Pharma Biotechnology and Pharmaceuticals Bristol Myers Squibb business Cancer Clinical trial conference Deal Eli Lilly European Commission European Union Facebook FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News
Tag Archives: Advertising
Pfizer Quietly Updates Company Logo
A few weeks back, about the time Pfizer started swapping out Wyeth signs for Pfizer branding, I was tipped off that the age-old Pfizer logo had been modified from the horizontal blue oval to an offset design.
Additionally, the company did tiny modifications on each letter, dropping the serif from the “P,” making the “F” less [...]
Feds Chase Down Faulty Skincare Promos
FDA’s Division of Drug Marketing Communications, this week, posted a slew of warning and untitled letters to pharma firms for misleading skincare advertisements. Johnson & Johnson, Galderma, and Allergan each received a letter documenting complaints ranging from false advertising to unsubstantial efficacy claims.
J&J received a violation letter in response to a journal ad for its [...]
Posted in FDA, Marketing Also tagged Allergan, Clinical trial, Johnson & Johnson, U.S. Food and Drug Administration Leave a comment
Building a Better Brief Summary
Image via Wikipedia
FDA wanted to find out what people really think of the risk information printed on the back of pharmaceutical advertising. Surprise, people tend to absorb far less information from the giant blocks of text printed in drab language.
DDMAC social science analyst Amy O’Donoghue explained FDA’s recent study results to an audience of marketers [...]

Google Unveils New Pharma Ads